Results 121 to 130 of about 1,273,061 (149)

[Aggressive NK-cell leukemia with CD5(+)CD10(-) monoclonal B cell lymphocytosis and hemophagocytic lymphohistiocytosis: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Liu M, Liu XJ, Zhou Y, Zhang MN, Hao D, Shi M.   +5 more
europepmc   +1 more source

[Staging<b>-</b>based integrative treatment strategies of traditional Chinese and Western Medicine for zoster<b>-</b>associated pain]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Shan H, Miao J, Guo X, Ding L, Geng W, Feng Z.   +5 more
europepmc   +1 more source

[Environmental relative humidity, frailty, and risk of incident stroke among middle-aged and older adults in China: A prospective cohort study]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhou Y, Zhang M, Ding H, Zheng J, Yang Y, Cui Y.   +5 more
europepmc   +1 more source

Performance Gaps and Optimization Strategies in Chinese Medical Large Language Models Based on MedBench: Evaluation Study. [PDF]

JMIR AI
Jiang L, Chen J, Lu L, Peng X, Liu L, He J, Xu J.   +6 more
europepmc   +1 more source

[<i>Angelica sinensis</i> promotes thymic cortical regeneration in mice with acute thymic involution induced by short-term rapamycin treatment]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Xu X, Shu Y, Gao J.
europepmc   +1 more source

[A compulsory course in clinical treatment of burn patients: pain and analgesia]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Nie FF.
europepmc   +1 more source

[Research progress in mechanisms of dietary resistant starch for regulating glucose and lipid metabolism]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu K, Li X, Zhang Y, Sun J, Liao W.
europepmc   +1 more source

[Epidemiological characteristics of adult inpatients with diabetes-related chronic non-healing wounds in Hainan province]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Yao JL, Li JX, Ming XC, Gu YT, Jiang T, Yang J, Bian YY, Zheng LY, Wang R, Zeng YF, Cheng SW.   +10 more
europepmc   +1 more source

[Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Mi XR, Xiong WJ, Yan YT, Wang TY, An G, Zou DH, Xu Y, Liu W, Qiu LG, Lyu R, Yi SH.   +10 more
europepmc   +1 more source